Need professional-grade analysis? Visit stockanalysis.com
$978.19M
415.33
178
N/A
Kuros Biosciences AG (KURN) trades on SIX Swiss Exchange in CHF. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CHF23.02, down 7.62% from the previous close.
Over the past year, KURN has traded between a low of CHF21.60 and a high of CHF33.36. The stock has gained 5.0% over this period. It is currently 31.0% below its 52-week high.
Kuros Biosciences AG has a market capitalization of $978.19M, with a price-to-earnings ratio of 415.33.
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Side-by-side comparison against top Healthcare peers.